ReviewClinical and molecular hepatology2023

Safety considerations for withdrawal of nucleos(t)ide analogues in patients with chronic hepatitis B: First, do no harm.

Yao-Chun Hsu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.